Skip to main navigation

Investors

Press Releases

Press Releases

All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2016

January 29, 2025

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

January 8, 2025

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

December 31, 2024

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

December 19, 2024

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

December 18, 2024

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

November 29, 2024

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

November 18, 2024

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

November 18, 2024

Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

November 16, 2024

Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024

November 6, 2024

Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 31 - 40 of 196

Tools

Print

Print
Email Alerts

Email Alerts
Investor Contacts

Investor Contacts

IR Nav

Investors
Press Releases
Presentations & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

IR Nav

Investors
Press Releases
Presentations & Events
- Stock Quote & Chart
- Analyst Coverage
- Governance Highlights
- Leadership and Board of Directiors
Financial Information

Adicet - Header Navigation

About
Science
Pipeline
Investors
Careers
- Join Our Team
- Current Openings
Contact

IR Nav

Investors
Press Releases
Presentations & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
- Governance Highlights
- Leadership and Board of Directiors
Financial Information
Investor Resources

© 2026 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.